1.
Actas dermo-sifiliogr. (Ed. impr.)
; 115(2): 215-217, feb. 2024. tab, ilus
Article
Es
| IBECS
| ID: ibc-230348
2.
Actas dermo-sifiliogr. (Ed. impr.)
; 115(2): t215-t217, feb. 2024. ilus, tab
Article
En
| IBECS
| ID: ibc-230349
3.
Actas Dermosifiliogr
; 115(2): 215-217, 2024 Feb.
Article
En, Es
| MEDLINE
| ID: mdl-37356545
Hemangioma, Capillary , Hemangioma , Skin Neoplasms , Humans , Infant , Propranolol/therapeutic use , Nadolol/therapeutic use , Hemangioma, Capillary/drug therapy , Hemangioma/drug therapy , Adrenergic beta-Antagonists/therapeutic use , Treatment Outcome , Skin Neoplasms/drug therapy , Administration, Oral
4.
Actas Dermosifiliogr
; 115(2): T215-T217, 2024 Feb.
Article
En, Es
| MEDLINE
| ID: mdl-38048940
Hemangioma, Capillary , Hemangioma , Skin Neoplasms , Humans , Infant , Propranolol/therapeutic use , Nadolol/therapeutic use , Hemangioma, Capillary/drug therapy , Hemangioma/drug therapy , Adrenergic beta-Antagonists/therapeutic use , Treatment Outcome , Skin Neoplasms/drug therapy , Administration, Oral